BOAA
DXCM icon

Bank of Ann Arbor’s DexCom DXCM Stock Holding History

Bank of Ann Arbor’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.4K Buy
+480
New +$39.9K 0.01% 320

Other funds holding DXCM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Bank of Ann Arbor's DXCM Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in DexCom (DXCM) in Q3 2026: 480 shares worth $41.4K. The stake represents 0.01% of the portfolio and ranks #320 among its holdings.

863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Bank of Ann Arbor held 480 shares of DexCom worth $41.4K as of Q3 2026.
  • DexCom was a new Bank of Ann Arbor position in Q3 2026.
  • DexCom made up 0.01% of Bank of Ann Arbor's portfolio in Q3 2026, its #320 holding.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.